Venture Planning Group, Feb 2010, Pages: 12
: MolecularDiagnostics Market Forecasts by Country The 2011 GlobalMolecularDiagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country
Takeda Pacific, July 2008, Pages: 175
.MolecularDiagnostics Market Landscape
Biomarkers, `Omics' and MolecularTests
An Expanding Definition of MolecularDiagnosticTests
The Global In Vitro Diagnostic Product and Clinical
Lab Service
Renub Research, July 2011, Pages: 92
at source globally and features the latest available data covering:
- GlobalMolecularDiagnostics Market (2008 to 2014)
- Top 8 application wise moleculardiagnostics (Infectious Disease Testing, Blood
Jain PharmaBiotech, Feb 2012, Pages: 1029
screening and cancer. Genetic screening tests, despite some restrictions is a promising area for future expansion of in vitro diagnostic market. Moleculardiagnostics is being combined with therapeutics
Bizacumen Inc., Nov 2009, Pages: 277
: Percentage Breakdown of Leading Players in the
Worldwide Genetic Testing Market - 2006
Table 5: Percentage Breakdown of Worldwide Cancer DiagnosticTesting Market - 2006
Table 6: GlobalMolecularDiagnostics
TriMark Publications, July 2011, Pages: 335
Gene
7.73 U.S. Genetics, Inc.
7.74 Veredus Laboratories
7.75 Veridex
8. Market Overview
8.1 Snapshot of MolecularDiagnostics Industry Structure
8.2 GlobalMolecularDiagnosticsTesting Market
8.3 U
Global Industry Analysts, Inc., Oct 2010, Pages: 659
This report analyzes the worldwide markets for MolecularDiagnostics in US$ million by the following segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening.
The report
Infiniti Research Limited, Feb 2010, Pages: 22
MolecularDiagnostics is the clinical application of molecular biology technologies, used in disease management. It consists of screening and diagnosticstests - using genetic material (DNA and RNA
TriMark Publications, July 2011, Pages: 214
and Comparison of Methods
4.2.3 Competitive Structure and Market Share Analysis
4.2.3.1 Breast Cancer MolecularDiagnosticTesting Market Size
4.2.3.1.1 Global Market
4.2.3.1.2 U.S. Market
4.2.3.1.3 European
Global Industry Analysts, Inc., Sep 2011, Pages: 794
Distribution Agreement with Roche Molecular Systems 58
Clovis Enters Agreement with Ventana for Developing Companion
DiagnosticTest US 58
Koncept Analytics, June 2011, Pages: 43
for moleculardiagnostictests and together account for a lion’s share in the global market. But in the coming years, with the increasing per capita income, and rising concern regarding healthy living
Frost & Sullivan, March 2008, Pages: 32
POC Testing for Infectious Diseases Gains Traction in the European Molecular POC Testing Markets
Point of care (POC) diagnostics market has experienced great success due to its benefits of advanced
Venture Planning Group, Feb 2010, Pages: 1050
Group, the globalmoleculardiagnostics market is growing at the rate of 18% a year, and is expected to reach $10 billion in 5 years. The most rapid growth is projected for genetic and cancer tests
Business Insights, June 2011, Pages: 187
This report analyzes current and potential world markets for key cancer-based moleculardiagnostics, including advances in the field. This report forecasts future growth to 2016. Market segments
Venture Planning Group, Nov 2011, Pages: 850
and market shares of leading suppliers.
- Over 60 specific opportunities for moleculardiagnostic instruments, test systems, IT and auxiliary products.
- Profiles of major suppliers, and emerging market entrants
TriMark Publications, July 2011, Pages: 365
Expression
Figure 2.4: Overall Structure of Nucleic Acid Testing Market
Figure 2.5: Global Market for MolecularDiagnostics, 2002-2016
Figure 3.1: Global Market for MolecularDiagnosticsTesting, 2010
TriMark Publications, May 2011, Pages: 3057
DiagnosticTesting Markets
- Companion Diagnostics in Personalized Medicine and Cancer Therapy
- High-Growth DiagnosticTesting Markets
- Key DiagnosticTesting Markets
- MolecularDiagnostics in Cancer
JZMed Inc., Jan 2011, Pages: 282
history) in genomics and proteomics, molecular biomarker, diagnostics and medical device.
- The report also conducted in-depth analyses with regards to the overall global R&D climate for genomics
